Clinical Trials Logo

Impotence clinical trials

View clinical trials related to Impotence.

Filter by:

NCT ID: NCT00547352 Completed - Impotence Clinical Trials

Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

Start date: June 2004
Phase: Phase 4
Study type: Interventional

To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.

NCT ID: NCT00547287 Completed - Impotence Clinical Trials

Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations

Start date: November 2002
Phase: Phase 3
Study type: Interventional

Study to determine if men from around the world prefer sildenafil to tadalafil.

NCT ID: NCT00547183 Completed - Impotence Clinical Trials

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

Start date: October 2004
Phase: Phase 3
Study type: Interventional

Study to evaluate the safety and effectiveness of 2.5 mg and 5 mg tadalafil when taken by men with diabetes mellitus who have problems getting and maintaining an erection.

NCT ID: NCT00547092 Completed - Impotence Clinical Trials

Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection

Start date: October 2003
Phase: Phase 4
Study type: Interventional

To determine if men prefer tadalafil or sildenafil for getting and keeping an erection after treatment with both drugs.

NCT ID: NCT00517179 Completed - Clinical trials for Prostatic Hyperplasia

Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS

Start date: April 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the interaction between doxazosin GITS and vardenafil on blood pressure (Both systolic and diastolic blood pressure) in patients with both ED and BPH.

NCT ID: NCT00498680 Recruiting - Impotence Clinical Trials

Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i

Start date: March 2007
Phase: Phase 4
Study type: Interventional

A prospective, randomized, 3-arm parallel trial on 45 males with ED that were never exposed to PDE5i therapy (naïve patients) will be enrolled.In each group, every patient will receive three treatment regimes (Viagra®50mg & Levitra®10mg, Viagra®100mg, Levitra®20mg), in different sequences of administration in such a manner that eventually each patient will receive all regimes in a double- blinded fasion.Safety will be evaluated at pre- screening by measuring hourly vital signs (blood pressure, heart rate)for 4 consecutive hours after taking half-dose combination. Any decrease in blood pressure of 20 mmhg below baseline will exclude the subject from the study. Effcacy will be evaluated by questionnaires (IIEF, Quality of erection questionnaire, grade of erection scale, Sear, QVS and Sexual Encounter Profiles for each sexual event). Non-parametric statistical analysis of the collected data Comparing the 3 groups will be performed.

NCT ID: NCT00422734 Completed - Impotence Clinical Trials

Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life

Start date: November 2006
Phase: Phase 3
Study type: Interventional

To determine if tadalafil 5 mg daily compared to placebo when given for 12 weeks improves getting and maintaining an erection in men with erectile dysfunction and if there are improvements in the sexual quality of life of the man and his female study partner

NCT ID: NCT00422578 Completed - Clinical trials for Erectile Dysfunction

Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction

Start date: October 2004
Phase: Phase 4
Study type: Interventional

Study is a clinical study assessing the effect of oral tadalafil 10mg or 20 mg on psychosocial aspects and quality of life of erectile dysfunction patients and to compare tadalafil with previous oral erectile dysfunction medication. Study period is 13 weeks. Study patients fill in quality of life questionnaires and treatment satisfaction questionnaires.

NCT ID: NCT00382161 Withdrawn - Impotence Clinical Trials

Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine the effect of fluvastatin on penile arterial blood flow and erectile function in patients with arteriogenic ED and cardiovascular risk factors.

NCT ID: NCT00343200 Completed - Impotence Clinical Trials

A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.

Start date: July 2006
Phase: Phase 4
Study type: Interventional

To compare the efficacy and safety of Viagra (sildenafil citrate) vs. placebo for the treatment of men with ED and at least 1 prespecified risk factor who do not self identify as having ED.